Efg Asset Management (North America) Corp. Halozyme Therapeutics, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $705 Million
- Q4 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 128,294 shares of HALO stock, worth $7.46 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
128,294
Previous 108,413
18.34%
Holding current value
$7.46 Million
Previous $6.2 Million
1.11%
% of portfolio
0.87%
Previous 1.06%
Shares
13 transactions
Others Institutions Holding HALO
# of Institutions
545Shares Held
121MCall Options Held
419KPut Options Held
172K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$772 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$385 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$236 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.07MShares$178 Million0.05% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.09B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...